On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Florence I. Raynaud

ResearcherPublications, citations & collaboration network

Florence I. Raynaud is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Florence I. Raynaud have?

ScholarIQindexed works

Florence I. Raynaud has 721 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Florence I. Raynaud have?

ScholarIQcitation count

Florence I. Raynaud has 18,299 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Florence I. Raynaud?

ScholarIQh-index

Florence I. Raynaud has an h-index of 75 in OpenAlex.

What is the i10-index of Florence I. Raynaud?

ScholarIQi10-index

Florence I. Raynaud has an i10-index of 181 in OpenAlex.

What is the ORCID of Florence I. Raynaud?

ScholarIQorcid

The ORCID for Florence I. Raynaud is on the source record.

What is the OpenAlex record for Florence I. Raynaud?

ScholarIQopenalex

The OpenAlex for Florence I. Raynaud is on the source record.

What are the most-cited papers on Florence I. Raynaud?

ScholarIQmost cited works
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Gerhardt Attard, Alison Reid, Timothy A. Yap, Florence I. Raynaud, Mitch Dowsett, S. Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd, Jeremy Clark, Colin S. Cooper, Stan B. Kaye, David P. Dearnaley, Gloria Lee, Johann S. de Bono
Journal of Clinical Oncology. 2008903 CitationsOPEN ACCESS
Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies
Udai Banerji, Anne O’Donnell, Michelle Scurr, Simon Pacey, Sarah Stapleton, Yasmin J. Asad, Laura K. Simmons, Alison Maloney, Florence I. Raynaud, Maeli Campbell, Michael I. Walton, Sunil R. Lakhani, Stanley B. Kaye, Paul Workman, Ian Judson
Journal of Clinical Oncology. 2005491 CitationsOPEN ACCESS
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
Debashis Sarker, Joo Ern Ang, Richard D. Baird, Rebecca Kristeleit, Krunal Shah, Víctor Moreno, Paul A. Clarke, Florence I. Raynaud, Gallia G. Levy, Joseph A. Ware, Kathryn Mazina, Ray Lin, Jenny Wu, Jill Fredrickson, Jill M. Spoerke, Mark R. Lackner, Yibing Yan, Lori S. Friedman, Stan B. Kaye, Mika K. Derynck, Paul Workman, Johann S. de Bono
Clinical Cancer Research. 2014362 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account